{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T03:27:43Z","timestamp":1788492463677,"version":"build-2803163510"},"reference-count":68,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":81,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Prostate"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1002\/pros.23007","type":"journal-article","created":{"date-parts":[[2015,6,12]],"date-time":"2015-06-12T16:43:25Z","timestamp":1434127405000},"page":"1227-1246","source":"Crossref","is-referenced-by-count":51,"title":["CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models"],"prefix":"10.1002","volume":"75","author":[{"given":"Giovanni Luca","family":"Gravina","sequence":"first","affiliation":[{"name":"Division of Radiation Oncology; Department of Biotechnological and Applied Clinical Sciences; University of L'Aquila; L'Aquila Italy"},{"name":"Department of Biotechnological and Applied Clinical Sciences; Laboratory of Radiobiology; University of L'Aquila; L'Aquila Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Mancini","sequence":"additional","affiliation":[{"name":"Department of Biotechnological and Applied Clinical Sciences; Laboratory of Radiobiology; University of L'Aquila; L'Aquila Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Muzi","sequence":"additional","affiliation":[{"name":"Department of Life; Health and Environmental Sciences; L'Aquila Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Ventura","sequence":"additional","affiliation":[{"name":"Pathology Department; San Salvatore Hospital L'Aquila; L'Aquila Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leda","family":"Biordi","sequence":"additional","affiliation":[{"name":"Department of Biotechnological and Applied Clinical Sciences; Laboratory of Molecular Pathology; University of L'Aquila; L'Aquila Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Ricevuto","sequence":"additional","affiliation":[{"name":"Department of Biotechnological and Applied Clinical Sciences; Laboratory of Molecular Pathology; University of L'Aquila; L'Aquila Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Pompili","sequence":"additional","affiliation":[{"name":"Department of Biotechnological and Applied Clinical Sciences; Laboratory of Human Anatomy; L'Aquila Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Mattei","sequence":"additional","affiliation":[{"name":"Department of Biotechnological and Applied Clinical Sciences; Laboratory of Radiobiology; University of L'Aquila; L'Aquila Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Di Cesare","sequence":"additional","affiliation":[{"name":"Division of Radiation Oncology; Department of Biotechnological and Applied Clinical Sciences; University of L'Aquila; L'Aquila Italy"},{"name":"Department of Biotechnological and Applied Clinical Sciences; Laboratory of Radiobiology; University of L'Aquila; L'Aquila Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuele A.","family":"Jannini","sequence":"additional","affiliation":[{"name":"Department of Systems Medicine; University of Tor Vergata; Roma Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Festuccia","sequence":"additional","affiliation":[{"name":"Department of Biotechnological and Applied Clinical Sciences; Laboratory of Radiobiology; University of L'Aquila; L'Aquila Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,6,12]]},"reference":[{"key":"10.1002\/pros.23007-BIB0001|pros23007-cit-0001","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.ejca.2009.12.014","article-title":"Estimates of cancer incidence and mortality in Europe in 2008","volume":"46","author":"Ferlay","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1002\/pros.23007-BIB0002|pros23007-cit-0002","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.2741\/2311","article-title":"Biology and clinical management of prostate cancer bone metastasis","volume":"2","author":"Ye","year":"2007","journal-title":"Front Biosci"},{"key":"10.1002\/pros.23007-BIB0003|pros23007-cit-0003","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.urolonc.2007.05.010","article-title":"Therapeutic options for hormone-refractory prostate cancer in","volume":"25","author":"Hadaschik","year":"2007","journal-title":"Urol Oncol"},{"key":"10.1002\/pros.23007-BIB0004|pros23007-cit-0004","doi-asserted-by":"crossref","first-page":"4440","DOI":"10.2174\/092986711797287539","article-title":"Clinical trial update and novel therapeutic approaches for metastatic prostate cancer","volume":"18","author":"Larsson","year":"2011","journal-title":"Curr Med Chem"},{"key":"10.1002\/pros.23007-BIB0005|pros23007-cit-0005","doi-asserted-by":"crossref","first-page":"424","DOI":"10.4161\/cam.21559","article-title":"Occupy tissue: The movement in cancer metastasis","volume":"6","author":"Bradbury","year":"2012","journal-title":"Cell Adh Migr"},{"key":"10.1002\/pros.23007-BIB0006|pros23007-cit-0006","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.ejcb.2012.04.005","article-title":"Pathological roles of invadopodia in cancer invasion and metastasis","volume":"91","author":"Yamaguchi","year":"2012","journal-title":"Eur J Cell Biol"},{"key":"10.1002\/pros.23007-BIB0007|pros23007-cit-0007","first-page":"17","article-title":"Osteoblasts modulate secretion of urokinase-type plasminogen activator (uPA) and matrix metalloproteinase-9 (MMP-9) in human prostate cancer cells promoting migration and matrigel invasion","volume":"11","author":"Festuccia","year":"1999","journal-title":"Oncol Res"},{"key":"10.1002\/pros.23007-BIB0008|pros23007-cit-0008","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0959-8049(00)00436-6","article-title":"Melanoma cells stimulate osteoclastogenesis, c-Src expression and osteoblast cytokines","volume":"37","author":"Perez","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1002\/pros.23007-BIB0009|pros23007-cit-0009","first-page":"419","article-title":"Human prostatic tumour cells in culture produce growth and differentiation factors active on osteoblasts: A new biological and clinical parameter for prostatic carcinoma","volume":"9","author":"Festuccia","year":"1997","journal-title":"Oncol Res"},{"key":"10.1002\/pros.23007-BIB0010|pros23007-cit-0010","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1096\/fj.03-0935fje","article-title":"Role of high expression levels of CXCR4 in tumour growth, vascularisation, and metastasis","volume":"18","author":"Darash-Yahana","year":"2004","journal-title":"FASEB J"},{"key":"10.1002\/pros.23007-BIB0011|pros23007-cit-0011","doi-asserted-by":"crossref","first-page":"8604","DOI":"10.1158\/0008-5472.CAN-04-1844","article-title":"CXCR4 regulates growth of both primary and metastatic breast cancer","volume":"64","author":"Smith","year":"2004","journal-title":"Cancer Res"},{"key":"10.1002\/pros.23007-BIB0012|pros23007-cit-0012","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1349-7006.2007.00712.x","article-title":"Chemokine receptor CXCR4 expression and prognosis in patients with metastatic prostate cancer","volume":"99","author":"Akashi","year":"2008","journal-title":"Cancer Sci"},{"key":"10.1002\/pros.23007-BIB0013|pros23007-cit-0013","first-page":"291","article-title":"The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis","volume":"4","author":"Arya","year":"2004","journal-title":"J Exp Ther Oncol"},{"key":"10.1002\/pros.23007-BIB0014|pros23007-cit-0014","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1476-4598-5-56","article-title":"Stromal derived factor-1 (SDF-1\/CXCL12) and CXCR4 in renal cell carcinoma metastasis","volume":"5","author":"Pan","year":"2006","journal-title":"Mol Cancer"},{"key":"10.1002\/pros.23007-BIB0015|pros23007-cit-0015","first-page":"1832","article-title":"Use of the stromal cell-derived factor-1\/CXCR4 pathway in prostate cancer metastasis to bone","volume":"62","author":"Taichman","year":"2002","journal-title":"Cancer Res"},{"key":"10.1002\/pros.23007-BIB0016|pros23007-cit-0016","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.2174\/138161210794455003","article-title":"CXCL12-CXCR4 axis in angiogenesis, metastasis and stem cell mobilization","volume":"16","author":"Liekens","year":"2010","journal-title":"Curr Pharm Des"},{"key":"10.1002\/pros.23007-BIB0017|pros23007-cit-0017","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/path.2908","article-title":"The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K\/AKT signalling","volume":"224","author":"Ping","year":"2011","journal-title":"J Pathol"},{"key":"10.1002\/pros.23007-BIB0018|pros23007-cit-0018","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1042\/CBI20100744","article-title":"Regulation of VEGF, MMP-9 and metastasis by CXCR4 in a prostate cancer cell line","volume":"35","author":"Wang","year":"2011","journal-title":"Cell Biol Int"},{"key":"10.1002\/pros.23007-BIB0019|pros23007-cit-0019","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.oraloncology.2012.01.006","article-title":"The role of IL-8 in the SDF-1\u03b1\/CXCR4-induced angiogenesis of laryngeal and hypopharyngeal squamous cell carcinoma","volume":"48","author":"Li","year":"2012","journal-title":"Oral Oncol"},{"key":"10.1002\/pros.23007-BIB0020|pros23007-cit-0020","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/pros.20318","article-title":"CXCL12\/CXCR4 signalling activates Akt-1 and MMP-9 expression in prostate cancer cells: The role of bone microenvironment-associated CXCL12","volume":"66","author":"Chinni","year":"2006","journal-title":"Prostate"},{"key":"10.1002\/pros.23007-BIB0021|pros23007-cit-0021","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1593\/neo.05694","article-title":"CXCR4 chemokine receptor mediates prostate tumour cell adhesion through alpha5 and beta3 integrins","volume":"8","author":"Engl","year":"2006","journal-title":"Neoplasia"},{"key":"10.1002\/pros.23007-BIB0022|pros23007-cit-0022","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/pros.20500","article-title":"Expression and activation of alpha v beta 3 integrins by SDF-1\/CXC12 increases the aggressiveness of prostate cancer cells","volume":"67","author":"Sun","year":"2007","journal-title":"Prostate"},{"key":"10.1002\/pros.23007-BIB0023|pros23007-cit-0023","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1349-7006.2012.02200.x","article-title":"Thromboxane A2 receptor signalling facilitates tumour colonisation through P-selectin-mediated interaction of tumour cells with platelets and endothelial cells","volume":"103","author":"Matsui","year":"2012","journal-title":"Cancer Sci"},{"key":"10.1002\/pros.23007-BIB0024|pros23007-cit-0024","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.3892\/or.2012.2028","article-title":"Silencing of CXCR4 by RNA interference inhibits cell growth and metastasis in human renal cancer cells","volume":"28","author":"Wang","year":"2012","journal-title":"Oncol Rep"},{"key":"10.1002\/pros.23007-BIB0025|pros23007-cit-0025","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1016\/j.ejca.2011.05.006","article-title":"RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously downregulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways","volume":"47","author":"Feng","year":"2011","journal-title":"Eur J Cancer"},{"issue":"24","key":"10.1002\/pros.23007-BIB0026|pros23007-cit-0026","doi-asserted-by":"crossref","first-page":"6206","DOI":"10.1182\/blood-2008-06-162123","article-title":"Mobilisation and chemosensitisation of AML with the CXCR4 antagonist plerixafor (AMD3100): A phase I\/II study of AMD3100 + MEC in patients with relapsed or refractory disease","volume":"113","author":"Nervi","year":"2009","journal-title":"Blood"},{"issue":"17","key":"10.1002\/pros.23007-BIB0027|pros23007-cit-0027","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1182\/blood-2011-10-383406","article-title":"A phase I\/II study of chemosensitisation with the CXCR4 antagonist plerixafor in relapsed or refractory AML","volume":"119","author":"Uy","year":"2012","journal-title":"Blood"},{"key":"10.1002\/pros.23007-BIB0028|pros23007-cit-0028","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1593\/neo.12324","article-title":"CXCR4 inhibition with AMD3100 sensitises prostate cancer to docetaxel chemotherapy","volume":"14","author":"Domanska","year":"2012","journal-title":"Neoplasia"},{"key":"10.1002\/pros.23007-BIB0029|pros23007-cit-0029","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jss.2012.09.035","article-title":"Effective inhibition of metastases and primary tumour growth with CTCE-9908 in oesophageal cancer","volume":"182","author":"Drenckhan","year":"2013","journal-title":"J Surg Res"},{"key":"10.1002\/pros.23007-BIB0030|pros23007-cit-0030","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jss.2008.06.044","article-title":"A CXCR4 antagonist CTCE-9908 inhibits primary tumour growth and metastasis of breast cancer","volume":"155","author":"Huang","year":"2009","journal-title":"J Surg Res"},{"key":"10.1002\/pros.23007-BIB0031|pros23007-cit-0031","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1002\/pros.21008","article-title":"Effects of CXCR4 antagonist CTCE-9908 on prostate tumour growth","volume":"69","author":"Porvasnik","year":"2009","journal-title":"Prostate"},{"key":"10.1002\/pros.23007-BIB0032|pros23007-cit-0032","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ejca.2010.09.028","article-title":"Blockade of CXCR4 in oral squamous cell carcinoma inhibits lymph node metastases","volume":"47","author":"Uchida","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1002\/pros.23007-BIB0033|pros23007-cit-0033","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.3748\/wjg.v17.i19.2389","article-title":"CXCR4\/SDF-1 axis is involved in lymph node metastasis of gastric carcinoma","volume":"17","author":"Zhao","year":"2011","journal-title":"World J Gastroenterol"},{"issue":"10","key":"10.1002\/pros.23007-BIB0034|pros23007-cit-0034","doi-asserted-by":"crossref","first-page":"e47287","DOI":"10.1371\/journal.pone.0047287","article-title":"Involvement of CXCR4 chemokine receptor in metastatic HER2-positive oesophageal cancer","volume":"7","author":"Gros","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1002\/pros.23007-BIB0035|pros23007-cit-0035","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/pros.21140","article-title":"Effects of transplantation of adipose tissue-derived stem cells on prostate tumour","volume":"70","author":"Lin","year":"2010","journal-title":"Prostate"},{"key":"10.1002\/pros.23007-BIB0036|pros23007-cit-0036","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1158\/1541-7786.MCR-07-0117","article-title":"CXCL12\/CXCR4 transactivates HER2 in lipid rafts of prostate cancer cells and promotes growth of metastatic deposits in bone","volume":"6","author":"Chinni","year":"2008","journal-title":"Mol Cancer Res ."},{"key":"10.1002\/pros.23007-BIB0037|pros23007-cit-0037","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2490-14-12","article-title":"Targeting CXCR4 with CTCE-9908 inhibits prostate tumor metastasis","volume":"14","author":"Wong","year":"2014","journal-title":"BMC Urol"},{"key":"10.1002\/pros.23007-BIB0038|pros23007-cit-0038","first-page":"1713","article-title":"Evaluation of metastatic potential in prostate carcinoma: An in vivo model","volume":"25","author":"Angelucci","year":"2004","journal-title":"Int J Oncol"},{"key":"10.1002\/pros.23007-BIB0039|pros23007-cit-0039","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1677\/erc.1.01100","article-title":"Suppression of EGF-R signaling reduces the incidence of prostate cancer metastasis in nude mice","volume":"13","author":"Angelucci","year":"2006","journal-title":"Endocr Relat Cancer"},{"key":"10.1002\/pros.23007-BIB0040|pros23007-cit-0040","first-page":"1627","article-title":"Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice","volume":"2","author":"Pettaway CA1","year":"1996","journal-title":"Clin Cancer Res"},{"key":"10.1002\/pros.23007-BIB0041|pros23007-cit-0041","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/pros.1065","article-title":"Bone metastatic LNCaP-derivative C4-2B prostate cancer cell line mineralizes in vitro","volume":"47","author":"Lin","year":"2001","journal-title":"Prostate"},{"key":"10.1002\/pros.23007-BIB0042|pros23007-cit-0042","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/6495","article-title":"A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2\/neu tyrosine kinase","volume":"5","author":"Craft","year":"1999","journal-title":"Nat Med"},{"key":"10.1002\/pros.23007-BIB0043|pros23007-cit-0043","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/jnci\/85.5.394","article-title":"Xenografts of primary human prostatic carcinoma","volume":"85","author":"Pretlow","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1002\/pros.23007-BIB0044|pros23007-cit-0044","first-page":"163","article-title":"VCaP, a cell-based model system of human prostate cancer","volume":"15","author":"Korenchuk","year":"2001","journal-title":"In Vivo"},{"key":"10.1002\/pros.23007-BIB0045|pros23007-cit-0045","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.3892\/ijo.2013.1892","article-title":"Phenotypic characterization of human prostatic stromal cells in primary cultures derived from human tissue samples","volume":"42","author":"Gravina","year":"2013","journal-title":"Int J Oncol"},{"key":"10.1002\/pros.23007-BIB0046|pros23007-cit-0046","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1756-8722-7-46","article-title":"XPO1\/CRM1-Selective Inhibitors of Nuclear Export (SINE) reduce tumor spreading and improve overall survival in preclinical models of prostate cancer (PCa)","volume":"7","author":"Gravina","year":"2014","journal-title":"J Hematol Oncol"},{"key":"10.1002\/pros.23007-BIB0047|pros23007-cit-0047","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/pros.10290","article-title":"Molecular characterization of human prostate carcinoma cell lines","volume":"57","author":"van Bokhoven","year":"2003","journal-title":"Prostate"},{"key":"10.1002\/pros.23007-BIB0048|pros23007-cit-0048","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1016\/j.ejca.2006.06.024","article-title":"Pyrazolo[3,4-d]pyrimidines c-Src inhibitors reduce epidermal growth factor-induced migration in prostate cancer cells","volume":"42","author":"Angelucci","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1002\/pros.23007-BIB0049|pros23007-cit-0049","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/excr.2002.5609","article-title":"Bombesindependent pro-MMP-9 activation in prostatic cancer cells requires beta1 integrin engagement","volume":"280","author":"Festuccia","year":"2002","journal-title":"Exp Cell Res"},{"key":"10.1002\/pros.23007-BIB0050|pros23007-cit-0050","first-page":"131","article-title":"Plasminogen activator activities in short-term tissue cultures of benign prostatic hyperplasia and prostatic carcinoma","volume":"7","author":"Festuccia","year":"1995","journal-title":"Oncol Res"},{"key":"10.1002\/pros.23007-BIB0051|pros23007-cit-0051","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1677\/ERC-07-0118","article-title":"Bicalutamide increases phospho-Akt levels through Her2 in patients with prostate cancer","volume":"14","author":"Festuccia","year":"2007","journal-title":"Endocr Relat Cancer"},{"key":"10.1002\/pros.23007-BIB0052|pros23007-cit-0052","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1530\/ERC-11-0045","article-title":"The TORC1\/TORC2 inhibitor, Palomid 529, reduces tumour growth and sensitises to docetaxel and cisplatin in aggressive and hormone-refractory prostate cancer cells","volume":"18","author":"Gravina","year":"2011","journal-title":"Endocr Relat Cancer"},{"key":"10.1002\/pros.23007-BIB0053|pros23007-cit-0053","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1158\/1078-0432.CCR-05-1671","article-title":"Synergistic antitumor activity of epidermal growth factor receptor tyrosine kinase inhibitor gefitinib and IFN-alpha in head and neck cancer cells in vitro and in vivo","volume":"12","author":"Bruzzese","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1002\/pros.23007-BIB0054|pros23007-cit-0054","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1158\/1078-0432.CCR-05-2050","article-title":"The bisphosphonate olpadronate inhibits skeletal prostate cancer progression in a green fluorescent protein nude mouse model","volume":"12","author":"Yang","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1002\/pros.23007-BIB0055|pros23007-cit-0055","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1593\/neo.12324","article-title":"CXCR4 inhibition with AMD3100 sensitizes prostate cancer to docetaxel chemotherapy","volume":"14","author":"Domanska UM1","year":"2012","journal-title":"Neoplasia ."},{"key":"10.1002\/pros.23007-BIB0056|pros23007-cit-0056","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/onc.2009.298","article-title":"PAUF functions in the metastasis of human pancreatic cancer cells and upregulates CXCR4 expression","volume":"29","author":"Lee","year":"2010","journal-title":"Oncogene"},{"key":"10.1002\/pros.23007-BIB0057|pros23007-cit-0057","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/path.2908","article-title":"The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K\/AKT signalling","volume":"224","author":"Ping","year":"2011","journal-title":"J Pathol"},{"key":"10.1002\/pros.23007-BIB0058|pros23007-cit-0058","first-page":"35","article-title":"Differential effects of TGF-\u03b21 and FGF-2 on SDF-1\u03b1 expression in human periodontal ligament cells derived from deciduous teeth in vitro","volume":"30","author":"Hasegawa","year":"2012","journal-title":"Int J Mol Med"},{"key":"10.1002\/pros.23007-BIB0059|pros23007-cit-0059","doi-asserted-by":"crossref","first-page":"9650","DOI":"10.1158\/0008-5472.CAN-10-1146","article-title":"P53 status in stromal fibroblasts modulates tumour growth in an SDF1-dependent manner","volume":"70","author":"Addadi","year":"2010","journal-title":"Cancer Res"},{"key":"10.1002\/pros.23007-BIB0060|pros23007-cit-0060","first-page":"761","article-title":"Inhibition of CXCR4 by CTCE-9908 inhibits breast cancer metastasis to lung and bone","volume":"21","author":"Richert","year":"2009","journal-title":"Oncol Rep"},{"key":"10.1002\/pros.23007-BIB0061|pros23007-cit-0061","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1002\/pros.21008","article-title":"Effects of CXCR4 antagonist CTCE-9908 on prostate tumor growth","volume":"69","author":"Porvasnik","year":"2009","journal-title":"Prostate"},{"key":"10.1002\/pros.23007-BIB0062|pros23007-cit-0062","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ejca.2010.09.028","article-title":"Blockade of CXCR4 in oral squamous cell carcinoma inhibits lymph node metastases","volume":"47","author":"Uchida","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1002\/pros.23007-BIB0063|pros23007-cit-0063","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1359\/JBMR.041109","article-title":"Skeletal localization and neutralization of the SDF-1(CXCL12)\/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo","volume":"20","author":"Sun","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1002\/pros.23007-BIB0064|pros23007-cit-0064","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jss.2008.06.044","article-title":"A CXCR4 antagonist CTCE-9908 inhibits primary tumor growth and metastasis of breast cancer","volume":"155","author":"Huang","year":"2009","journal-title":"J Surg Res"},{"key":"10.1002\/pros.23007-BIB0065|pros23007-cit-0065","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1002\/pros.21008","article-title":"Effects of CXCR4 antagonist CTCE-9908 on prostate tumor growth","volume":"69","author":"Porvasnik","year":"2009","journal-title":"Prostate"},{"key":"10.1002\/pros.23007-BIB0066|pros23007-cit-0066","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1158\/1541-7786.MCR-13-0029-T","article-title":"Residual prostate cancer cells after docetaxel therapy increase the tumorigenic potential via constitutive signaling of CXCR4, ERK1\/2 and c-Myc","volume":"11","author":"Hatano","year":"2013","journal-title":"Mol Cancer Res"},{"key":"10.1002\/pros.23007-BIB0067|pros23007-cit-0067","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00418-012-0998-0","article-title":"Expression of the E-cadherin repressors Snail, Slug and Zeb1 in urothelial carcinoma of the urinary bladder: Relation to stromal fibroblast activation and invasive behaviour of carcinoma cells","volume":"138","author":"Schulte","year":"2012","journal-title":"Histochem Cell Biol"},{"key":"10.1002\/pros.23007-BIB0068|pros23007-cit-0068","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s12032-013-0674-9","article-title":"Androgen receptor in human prostate cancer-associated fibroblasts promotes prostate cancer epithelial cell growth and invasion","volume":"30","author":"Yu","year":"2013","journal-title":"Med Oncol"}],"container-title":["The Prostate"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpros.23007","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/pros.23007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T04:29:37Z","timestamp":1625459377000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pros.23007"}},"subtitle":["CXCR4 Inhibition Has Anti-Tumor and Anti-Metastatic Effects in Prostate Cancer Models"],"short-title":[],"issued":{"date-parts":[[2015,6,12]]},"references-count":68,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,7]]}},"URL":"https:\/\/doi.org\/10.1002\/pros.23007","relation":{},"ISSN":["0270-4137"],"issn-type":[{"value":"0270-4137","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6,12]]}}}